Executives to drive company's development of
biomarker sensing solutions for health and wellness
Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a
global leader in photonics-based health monitoring and
communications solutions, today announced several senior leadership
promotions to further accelerate the development of its biomarker
sensing platform and to drive its opportunity in healthcare.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220215005508/en/
Andrew Rickman Congratulates Promoted
Executives: Top Row: Left to Right – Hooman Abediasl, Andrew
Rickman, Roozbeh Parsa; Bottom Row: Left to Right – Ben VerSteeg,
Sanjiv Kappor, Casimir Wierzynski (Photo: Business Wire)
Rockley announced the following executive vice president
promotions:
- Hooman Abediasl, Ph.D. in electrical engineering, University of
Southern California, first prize winner of the prestigious Nokia
Bell Labs award and an Annenberg Fellow, has been promoted to EVP
of product engineering. Abediasl is a co-founder of Rockley’s
sensing product technology and brings a strong technical leadership
background in laser-based imaging and sensing to his role.
- Sanjiv Kapoor, Ph.D. in materials science and engineering,
Stanford University, has been promoted to EVP of operations,
process technology and manufacturing. Kapoor authored eight patents
and 18 peer-reviewed publications. He is a leader in high-volume
production of biometric sensing solutions for consumer products. He
has extensive experience in transitioning multiple technologies
from “lab to fab,” including various MEMS sensors for
TDK-InvenSense and III-V devices for communications applications.
Kapoor also led the manufacturing ramp of a fuel cell technology
for a clean tech pioneer.
- Roozbeh Parsa, Ph.D. in electrical engineering, Stanford
University, has been promoted to EVP of commercial. Parsa authored
or co-authored over 25 U.S. patents. He has extensive technical and
commercial experience in semiconductor and optical MEMS sensing.
With a successful track record in health monitoring application
technology, Parsa’s background in developing products from
incubation to market release makes him well qualified to lead
Rockley’s product strategy, sales, marketing, and business
development efforts.
Rockley announced the following senior vice president
promotions:
- Casimir Wierzynski, Ph.D. in computation and neural systems,
California Institute of Technology, has been promoted to SVP of
cloud and AI. Wierzynski holds multiple U.S. patents and patents
pending in the fields of autonomous robotics, neuromorphic
computing, and machine learning. He brings significant leadership
experience as a senior director of AI at Intel, where he launched
the private AI and analytics business, providing hardware and
software technology to support machine learning on encrypted data.
Wierzynski’s background also includes leading complex technology
and engineering teams to solve high-impact problems using AI.
- Benjamin VerSteeg, B.S. in electrical and biomedical
engineering, Harvey Mudd College, has been promoted to SVP of
sensing product development. VerSteeg was the co-founder and CEO of
TruTouch Technologies, which developed the first commercial
predicate to Rockley’s wearable sensor technology and was acquired
by the company. He was also the founder and CTO of MoreLight. He is
the author of multiple patents and publications in optical
biosensing. VerSteeg brings over 20 years of experience in the
invention and commercialization of non-invasive optical sensors to
Rockley.
“I am excited by these key executive promotions and believe that
our team has the skills, drive, and determination to help Rockley
successfully execute our innovative approach to health and
wellness, utilizing our non-invasive, continuous biosensing
platform. These talented managers and proven leaders in their
fields have already demonstrated their world-class capabilities. I
am very proud of all the industry talent within Rockley,” said Dr.
Andrew Rickman, chairman and chief executive officer of Rockley.
“Our team of over 300 employees includes 109 Ph.D.s and 205
engineers, thrives on working with the amazing collection of
innovators that we’ve assembled, and is driven by the tremendous
opportunity ahead of us. We have an incredibly accomplished
management team and an operationally experienced board of
directors, all of whom are leaders in their field.”
Rockley consists of a team of innovative professionals from
leading semiconductor and medtech companies. These talented team
members have worked with leading companies and organizations,
including Bookham, Broadcom, Dexcom, Intel, InvenSense, iRhythm,
Lumentum, Masimo, Medtronic, Mellanox, NASA, and Texas Instruments,
among others.
Learn more information about Rockley’s leadership team.
About Rockley Photonics
A global leader in photonics-based health monitoring and
communications solutions, Rockley Photonics is developing a
comprehensive range of photonic integrated circuits and associated
modules, sensors, and full-stack solutions. From next-generation
sensing platforms specifically designed for mobile health
monitoring and machine vision to high-speed, high-volume solutions
for data communications, Rockley is laying the foundation for a new
generation of applications across multiple industries. Rockley
believes that photonics will eventually become as pervasive as
micro-electronics, and it has developed a platform with the power
and flexibility needed to address both mass markets and a wide
variety of vertical applications.
Formed in 2013, Rockley is uniquely positioned to support
hyper-scale manufacturing and address a multitude of high-volume
markets. Rockley has partnered with numerous tier-1 customers
across a diverse range of industries to deliver the complex optical
systems required to bring transformational products to market.
To learn more about Rockley, visit rockleyphotonics.com.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release that are not historical facts
constitute “forward-looking statements” for purposes of the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements include statements
regarding Rockley’s future expectations, beliefs, plans,
objectives, and assumptions regarding future events or performance.
The words “accelerate,” “advance,” “allow,” “anticipate,”
“believe,” “can,” “capability,” “continue,” “could,” “develop,”
“enable,” “estimate,” “eventual,” “expand, “expect,” “focus,”
“forward,” “future,” “goal,” “intend,” “may,” “might,”
“opportunity,” “outlook,” “plan,” “possible,” “position,”
“potential,” “predict,” “project,” “realize,” “revolutionize,”
“seem,” “should,” “trend,” “vision,” “will,” “would” or other terms
that predict or indicate future events, trends, or expectations,
and similar expressions or the negative of such expressions may
identify forward-looking statements, but the absence of these words
or terms does not mean that a statement is not forward-looking.
Forward-looking statements in this press release include, but are
not limited to, statements regarding the following: (a) the
potential of Rockley’s sensing platform to provide real-time
insights and clinical grade data about a variety of health
conditions from a wearable device; (b) the importance of the
ability to monitor key biomarkers on a continuous basis; (c) the
potential to leverage data collected from Rockley’s biomarking
sensing products to enable additional capability for the
fast-growing digital health domain; (d) Rockley’s belief that its
cloud and AI infrastructure can provide better information for
healthcare providers and greater peace of mind for people who’d
like meaningful insights into their health and well-being; and (e)
the anticipated and potential features, scope, goals, and benefits
of the Company’s platform, products, and technology.
Forward-looking statements are subject to several risks and
uncertainties (many of which are beyond Rockley’s control) or other
assumptions that may cause actual results or performance to differ
materially from those expressed or implied by these forward-looking
statements. These risks and uncertainties include, but are not
limited to, the following: (i) Rockley’s ability to achieve
customer acceptance and commercial production of its products and
technology, including in a timely and cost-effective manner; (ii)
Rockley’s ability to achieve customer design wins and convert
memoranda of understanding and development contracts into
production contracts; (iii) risks related to purchase orders,
including the lack of long-term purchase commitments, the
cancellation, reduction, delay, or other changes in customer
purchase orders, and if and to the extent customers seek to enter
into licensing arrangements in lieu of purchases; (iv) Rockley’s
history of losses and need for additional capital and its ability
to access additional financing to support its operations and
execute on its business plan, as well as the risks associated
therewith; (v) legal and regulatory risks; (vi) risks associated
with its fabless manufacturing model and dependency on third-party
suppliers; (vii) Rockley’s reliance on a few significant customers
for a majority of its revenue and its ability to expand and
diversify its customer base; (viii) Rockley’s financial
performance; (ix) the impacts of COVID-19 on Rockley, its customers
and suppliers, its target markets, and the global economy; (x)
Rockley’s ability to successfully manage growth and its operations
as a public company; (xi) fluctuations in Rockley’s stock price and
Rockley’s ability to maintain the listing of its ordinary shares on
the NYSE; (xii) Rockley’s ability to anticipate and respond to
industry trends and customer requirements; (xiii) changes in the
current and future markets in which Rockley is or may be engaged;
(xiv) risks related to competition and intellectual property; (xv)
market opportunity and demand for Rockley’s products and
technology, as well as the customer products into which Rockley’s
products and technology are incorporated; (xvi) risks related to
international operations; (xvii) risks related to cybersecurity,
privacy, and infrastructure; (xviii) risks related to financial and
accounting matters; (xix) general economic, financial, political,
and business conditions, both domestic and foreign; (xx) Rockley’s
ability to realize the anticipated benefits of its recently
completed business combination with SC Health Corporation; and
(xxi) Rockley’s ability to realize the anticipated benefits of
strategic partnerships, as well as other factors described under
the heading “Risk Factors” in Rockley’s quarterly report on Form
10-Q for the quarter ended September 30, 2021, and in other
documents Rockley files with the Securities and Exchange Commission
in the future.
The forward-looking statements contained in this press release
are based on various assumptions, whether or not identified in this
press release, and on Rockley’s current expectations, beliefs, and
assumptions and are not predictions of actual performance. If any
of these risks or uncertainties materialize, or should any of these
assumptions prove incorrect, actual results may differ materially
from those discussed in or implied by these forward-looking
statements. There can be no assurance that future developments
affecting Rockley will be those that have been anticipated. These
forward-looking statements speak only as of the date hereof and
Rockley does not intend to update or revise any forward-looking
statements, whether because of new information, future events, or
otherwise, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220215005508/en/
Media Debra Raine RaineMakers Telephone: +1 415-349-7432 Email:
rockley-pr@rainemakers.com
Investors Gwyn Lauber Rockley Photonics Telephone: +1
626-995-0001 Email: investors@rockleyphotonics.com
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Oct 2023 to Oct 2024